延長化建(600248.SH)擬購買陝建股份100%股份 明起停牌
格隆匯1月2日丨延長化建(600248.SH)公佈,經與有關各方論證和協商,公司擬以發行股份的方式向公司控股股東陝西建工控股集團有限公司(以下簡稱“陝建控股”)購買其持有的陝西建工集團股份有限公司(以下簡稱“陝建股份”)99%股份,向陝西建工實業有限公司(以下簡稱“陝建實業”)購買其持有的陝建股份1%股份,並吸收合併陝建股份,同時募集配套資金。本次重組構成《上市公司重大資產重組管理辦法》規定的重大資產重組,亦構成關聯交易。公司股票自2020年1月3日(星期五)開市起停牌,預計停牌時間不超過10個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.